A Study of Deucravacitinib to Treat LPP and FFA
Condition(s):Lichen PlanopilarisLast Updated:November 14, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Lichen PlanopilarisLast Updated:November 14, 2023Recruiting
Condition(s):Sjögren’s SyndromeLast Updated:March 13, 2024Recruiting
Condition(s):Psoriatic ArthritisLast Updated:March 22, 2024Recruiting
Condition(s):Palmoplantar Psoriasis; Genital PsoriasisLast Updated:March 8, 2024Recruiting
Condition(s):PsoriasisLast Updated:February 28, 2024Recruiting
Condition(s):Hidradenitis SuppurativaLast Updated:February 6, 2024Recruiting
Condition(s):Lupus Erythematosus, Discoid; Lupus Erythematosus, Subacute CutaneousLast Updated:March 7, 2024Recruiting
Condition(s):Plaque PsoriasisLast Updated:February 20, 2024Recruiting
Condition(s):Systemic Lupus ErythematosusLast Updated:February 28, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.